Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Madrigal Pharmaceuticals Inc. (MDGL)

195.195 6.015 (3.18%)

10-16 10:06

Open:

191.71

Pre. Close:

189.18

High:

195.195

Low:

190.47

Volume:

32,052

Market Cap:

2999M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

191.751 - 192.813

192.813 - 193.677

Low:

180.805 - 182.291

182.291 - 183.498

Close:

186.948 - 189.199

189.199 - 191.028

Technical analysis  (as of: 2018-10-15 4:40:49 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 254.61     One year: 280.59

Support:

Support1: 182.01    Support2: 151.43

Resistance:

Resistance1: 217.99    Resistance2: 240.23

Pivot:

204.28

Moving Averages:

MA(5): 190.58     MA(20): 207.12

MA(100): 248.05     MA(250): 159.24

MACD:

MACD(12,26): -10.93     Signal(12,26,9): -9.51

%K %D:

%K(14,3): 14.85     %D(3): 13.49

RSI:

RSI(14): 32.20

52-Week:

High: 325.98  Low: 38.82  Change(%): 302.4

Average Vol(K):

3-Month: 20731  10-Days 17141

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
MDGL has closed above bottom band by 15.8%. Bollinger Bands are 38.7% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-10-09T11:31:16-04:00
Madrigal Pharmaceuticals Presents Buying Opportunity Before Data Presentation

2018-10-08T22:35:03-04:00
Now Corbus Joins The NASH Fray

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

15.37

Shares Float (M)

6.69

% Held by Insiders

% Held by Institutions

52.80

Shares Short (K)

1405

Shares Short Prior Month (K)

Stock Financials

EPS

-2.250

EPS Est. Current Year

-2.670

EPS Est. Next Year

-3.560

EPS Est. Next Quarter

-0.750

Forward EPS

-5.819

Book Value (p.s.)

5.930

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-10.6

Return on Equity (ttm)

-10.8

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.544

Qtrly Earnings Growth

Operating Cash Flow (M)

-24.90

Levered Free Cash Flow (M)

-15.98

Valuation

P/E

-84.08

P/E Growth Ratio

-0.01

P/BV

31.90

P/S

P/CF

-116.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-07-25

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.